Deutsch Website, wo Sie Qualität und günstige Viagra Lieferung weltweit erwerben.

Zufrieden mit dem Medikament, hat mich die positive Meinung priligy kaufen Viagra empfahl mir der Arzt. Nahm eine Tablette etwa eine Stunde vor der Intimität, im Laufe der Woche.


Allard, R., Marshall, M., Plante, M-C. (1992). Intensive follow-up does not decrease the risk of repeat suicide attempts. Suicide and Life threatening behaviour, 22(3), 303-314. Andersen, U.A, Andersen, M., Rosholm, J.U., & Gram, L.F. (2001). Psychopharmacological treatment and psychiatric morbidity in 390 cases of suicide with special focus on affective disorders. Acta Psychiatrica Scandinavica, 104(6),458-465 Ankarberg, P.H. (2003). Antidepressant prescribing and suicide: Antidepressants do not reduce suicide rates. British Medical Journal, 327(7409), 288-289. Appleby, L., Shaw, J., Amos, T., McDonnell, R., Harris, C., McCann, K., Kiernan, K., Davies, S., Bickley, H., & Parsons, R. (1999). Suicide within 12 months of contact with mental health services: national clinical survey. British Journal of Medicine, 318(7193),1235-1239. Baldessarini, R.J., et al. (2003). Lithium treatment and suicide risk in major affective disorders: Update and new findings. Journal of Clinical Psychiatry, 64(5), 44-52. Beasley, C.M.Jr., Dornseif, B.E., Bosomworth, J.C., Sayler, M.E., Rampey, A.H.Jr., Heiligenstein, J.H., Thompson, V.L., Murphy, D.J., & Masica, D.N. (1991). Fluoxetine and suicide: a meta-analysis of controlled trials of treatment for depression. British Medical Journal, 303(6804),685-92. Bennewith, O., Stocks, N., Gunnell, D., Peters, T.J., Evans, M., & Sharp, D.J. (2002). General practice based intervention to prevent repeat episodes of deliberate self harm : cluster randomised controlled trial. British Medical Journal, 324, 1254-1257. Bernadt, M., & Hammill, R. (1995). Antidepressants and suicide. Study's conclusion is unwarranted. British Medical Journal, 311(6996), 56. Brent, D.A., Holder, D., Kolko, D., Birmaher, B., Baugher, M., Roth, C., Iyengar, S., & Johnson,B.A. (1997). A clinical psychotherapy trial for adolescent depression comparing cognitive, family, and supportive therapy. Archives of General Psychiatry, 54(9), 877-85. Brent, D.A. (1997). The aftercare of adolescents with deliberate self-harm. Journal of Child Psychology and Psychiatry and Allied Disciplines, 38(3), 277-286. Bridge JA, Iyengar S, Salary CB, Barbe RP, Birmaher B, Pincus HA, Ren L, Brent DA. (2007). Clinical response and risk for reported suicidal ideation and suicide attempts in pediatric antidepressant treatment: a meta-analysis of randomized controlled trials. JAMA, 297(15):1683-96. Canceil, O., Cottraux, J., Falissard, B., Flament, M., Miermont, J., Swendsen, J., Teherani, M., & Thurin, J.M. (2004). Psychothérapies – trois approches évaluées. Cedereke, M., Monti, K., & Ojehagen, A. (2002). Telephone contact with patients in the year after a suicide attempt: does it affect treatment attendance and outcome? A randomised controlled study. European Psychiatry, 17(2), 82-91. Cheeta, S., Schifano, F., Oyefeso, A., Webb, L., & Ghodse, A.H. (2004). Antidepressant-related deaths and antidepressant prescriptions in England and Wales, 1998-2000. British Journal of Psychiatry, 184(1), 41-47. Cipriani A, Pretty H, Hawton K, Geddes JR. (2005). Lithium in the prevention of suicidal behavior and all-cause mortality in patients with mood disorders: a systematic review of randomized trials. Am J Psychiatry, 162(10):1805-19 Cotgrove, A.J., Zirinsky, L., Black, D., &Weston, D. (1995). Secondary prevention of attempted suicide in adolescence. Journal of Adolescence, 18(5), 569-577. Donaldson, D., Spirito, A., Arrigan, M., & Aspel, J.W. (1997). Structured disposition planning for adolescent suicide attempters in a general hospital: Preliminary findings on short-term outcome. Archives of Suicide Research, 3(4): 271-282. Dubois, L., Walter, M., Bleton, L., Genest, E., Lemonier, E., Lachèvre, G., Dejean, Y., Le Coat, P., Kress, J.-J., & Lazartigues, A. (1999). Évaluation comparative et prospective d’un protocole de prise en charge spécifique de jeunes suicidants : analyse du diagnostic psychiatrique initial, de l’observance thérapeutique et du taux de récidive à un an (résultats préliminaires). Annales Médico-Psychologiques, 157(8), 557-561. Dudley, M., Beard, J., Clarke, A., Knowles, M., Buss, R., Schnieden, V., Einfeld, S., Tobin, M., & Dietrich, U. (2003). Effectiveness of a 'Green Card' intervention for patients engaging in deliberate self-harm. Archives of Suicide Research, 7(2), 175-181. Evans, M.O., Morgan, H.G., Hayward, A., & Gunnell, D.J. (1999b). Crisis telephone consultation for deliberate self-harm patients: Effects on repetition. British Journal of Psychiatry, 175, 23-27. Evans, M.O., Morgan, G., & Hayward, A. (2000). Crisis telephone consultation for deliberate self- harm patients: How the study groups used the telephone and usual health-care services. Journal of Mental Health, 9(2), 155-164. Evans, K., Tyrer, P., Catalan, J., Schmidt, U., Davidson, K., Dent, J., Tata, P., Thornton, S., Barber, J., & Thompson, S. (1999a). Manual-assisted cognitive-behaviour therapy (MACT): A randomized controlled trial of a brief intervention with bibliotherapy in the treatment of recurrent deliberate self-harm. Psychological Medicine, 29(1),19-25. Fergusson, D., Doucette, S., Glass, K.C., Shapiro, S., Healy, D., Hebert, P., & Hutton, B. (2005). Association between suicide attempts and selective serotonin reuptake inhibitors: systematic review of randomised controlled trials. British Medical Journal, 330(7488), 396. Gibbons, J.S., Butler, J., Urwin, P., & Gibbons, J.L. (1978). Evaluation of a social work service for self-poisoning patients. British Journal of Psychiatry, 133, 111-118. Gibbons, R.D., Hur, K., Bhaumik, D.K, & Mann, J.J. (2005). The Relationship Between Antidepressant Medication Use and Rate of Suicide. Archives of General Psychiatry, 62(2),165-172. Gibbons RD, Brown CH, Hur K, Marcus SM, Bhaumik DK, Erkens JA, Herings RM, Mann JJ. (2007). Early evidence on the effects of regulators' suicidality warnings on SSRI prescriptions and suicide in children and adolescents. Am J Psychiatry, 164(9):1356-63 Gibbons RD, Brown CH, Hur K, Marcus SM, Bhaumik DK, Mann JJ. (2007). Relationship between antidepressants and suicide attempts: an analysis of the Veterans Health Administration data sets. Am J Psychiatry, 164(7):1044-9. Greenfield, B., Larson, C., Hechtman, L., Rousseau, C., & Platt, R. (2002). A Rapid-Response Outpatient Model for Reducing Hospitalizadon Rates Among Suicidal Adolescents. Psychiatric Services, 53(12), 1574-1579. Grunebaum, M.F., Ellis, S.P., Li, S., Oquendo, M.A., & Mann, J.J. (2004). Antidepressants and Suicide Risk in the United States, 1985-1999, Journal of Clinical Psychiatry 65(11), 1456-1462. Gunnell, D., Saperia, J., & Ashby, D. (2005). Selective serotonin reuptake inhibitors (SSRIs) and suicide in adults: meta-analysis of drug company data from placebo controlled, randomised controlled trials submitted to the MHRA's safety review. British Medical Journal, 330(7488), 385. Gutstein, S.-E., & Rudd, M.D. (1990). An outpatient treatment alternative for suicidal youth. Guthrie, E., Kapur, N., Mackway-Jones, K., Chew-Graham, C., Moorey, J., Mendel, E., Marino- Francis, F., Sanderson, S., Turpin, C., Boddy, G., & Tomenson, B. (2001). Randomised controlled trial of brief psychological intervention after deliberate self poisoning. British Medical Journal, 323(7305), 1-5. Hammad TA, Laughren T, Racoosin J. (2006). Suicidality in pediatric patients treated with antidepressant drugs. Arch Gen Psychiatry, 63(3): 332-9. Harrington, R. (1998). Randomized trial of a home-based family intervention for children who have deliberately poisoned themselves. Journal of the American Academy of Child and Adolescent Psychiatry, 37(5), 512-518. Haw, C., Hawton, K., Whitehead, L., Houston, K., & Townsend, E. (2003). Assessment and aftercare for deliberate self-harm patients provided by a general hospital psychiatric service. Crisis, 24(4), 145-150. Haw, C., Houston, K., Townsend, E., & Hawton, K. (2002). Deliberate self harm patients with depressive disorders: Treatment and outcome. Journal of Affective Disorders, 70(1), 57-65. Hawton, K., Bancroft, J., Catalan, J., Kingston, B., Stedeford, A., & Welch, N. (1981). Domiciliary and out-patient treatment of self-poisoning patients by medical and non-medical staff. Psychological Medicine, 11(1), 169-77. Hawton, K., McKeown, S., Day, A., Martin, P., O'Connor, M., & Yule, J. (1987). Evaluation of out- patient counselling compared with general practitioner care following overdoses. Psychological Medicine, 17(3), 751-61. Hemels, M.E., Koren, G., & Einarson, T.R. (2002) Increased use of antidepressants in Canada: 1981-2000. The Annals of Pharmacotherapy, 36(9),1375-9. Hengeveld, M.W., Jonker, D.J.L., & Rooijmans, H.G.M. (1996). A pilot study of a short cognitive- behavioral group treatment for female recurrent suicide attempters. International Journal of Psychiatry in Medicine, 26(1), 83-91. Henriksson, S., Boëthius, G., & Isacsson, G. (2001). Suicides are seldom prescribed antidepressants: Findings from a prospective prescription database in Jämtland County, Sweden, 1985-95. Acta Psychiatrica Scandinavica, 103(4), 301-306. Henry, J.A., Alexander, C.A., & Sener, E.K. (1995). Relative mortality from overdose of antidepressants. British Medical Journal, 310(6974), 221-4. Hetrick SE, Merry SN, McKenzie J, Sindahl P, Proctor M. (2009). Selective serotonin reuptake inhibitors (SSRIs) for depressive disorders in children and adolescents (Review). The Cochrane Collaboration. Published by John Wiley & Sons, Ltd. Hirschfeld, R.M. (1999). Efficacy of SSRIs and newer antidepressants in severe depression: comparison with TCAs. Journal of Clinical Psychiatry, 60(5):326-35. Journal of Clinical Psychiatry, 60(5):326-35. Hirschfeld, R.M.A. (2000). Suicide and antidepressant treatment. Archives of General Psychiatry, Ilgen, M.A., Tiet, Q., & Moos, R. (2004). Outcomes of substance use disorder treatment in suicidal and nonsuicidal male patients. Journal of Studies on Alcohol, 65(5), 643-650. Isacsson, G., Bergman, U., & Rich, C.L. (1994). Antidepressants, depression and suicide: An analysis of the San Diego study. Journal of Affective Disorders, 32(4), 277-286. Isacsson, G., Holmgren, P., Ahlner, J., & Bergman, U. (2002). Antidepressants in 15,432 suicides in Sweden 1992-2000. European Psychiatry, 17(Suppl.1), 204-5. Isometsä, E., Henriksson, M.M., Aro, H.M., Heikkinen, M.E., Kuoppasalmi, K.I., & Lönnqvist, J.K. (1994). Suicide in Major Depression. American Journal of Psychiatry, 151(4), 530-536. Kapusta ND, Niederkrotenthaler T, Etzersdorfer E, Voracek M, Dervic K, Jandl-Jager E, Sonneck G. (2009). Influence of psychotherapist density and antidepressant sales on suicide rates. Acta Psychiatr Scand, 119(3):236-42. Katz, L.Y., Cox, B.J., Gunasekara, S., & Miller, A.L. (2004). Feasibility of dialectical behavior therapy for suicidal adolescent inpatients. Journal of the American Academy of Child & Adolescent Psychiatry, 43(3),276-282. Katz LY, Kozyrskyj AL, Prior HJ, Enns MW, Cox BJ, Sareen J. (2008). Effect of regulatory warnings on antidepressant prescription rates, use of health services and outcomes among children, adolescents and young adults. CMAJ, 178(8):1005-11. Khan, A., Khan, S., Kolts, R., & Brown, W.A. (2003). Suicide rates in clinical trials of SSRIs, other antidepressants, and placebo: Analysis of FDA reports. American Journal of Psychiatry, 160(4),790-792. Khan, A., Khan, S.R., Leventhal, R.M., & Brown, W.A. (2001). Symptom reduction and suicide risk in patients treated with placebo in antidepressant clinical trials: A replication analysis of the Food and Drug Administration Database. International Journal of Neuropsychopharmacology, 4(2), 113-118. Khan, A., Warner, H.A., & Brown, W.A. (2000). Symptom reduction and suicide risk in patients treated with placebo in antidepressant clinical trials: An analysis of the Food and Drug Administration database. Archives of General Psychiatry, 57(4), 311-317. King, E.A., Baldwin, D.S., Sinclair, J.M., & Campbell, M.J. (2001). The Wessex Recent In-Patient Suicide Study, 2. Case-control study of 59 in-patient suicides. British Journal of Psychiatry, 178, 537-42. Kurdyak PA, Juurlink DN, Mamdani MM. (2007). The effect of antidepressant warnings on prescribing trends in Ontario, Canada. Am J Public Health, 97(4):750-4. Lerner, M.-S., & Clum, G.-A. (1990). Treatment of suicide ideators: A problem-solving approach. Leucht S, Heres S, Hamann J, Kane JM. (2008). Methodological issues in current antipsychotic drug trials. Schizophr Bull, 34(2):275-85. Liberman, R.P., & Eckman, T. (1981). Behavior therapy vs insight-oriented therapy for repeated suicide attempters. Archives of General Psychiatry, 38(10), 1126-1130. Libby AM, Brent DA, Morrato EH, Orton HD, Allen R, Valuck RJ. (2007). Decline in treatment of pediatric depression after FDA advisory on risk of suicidality with SSRIs. Am J Psychiatry, 164(6):884-91. Linehan, M.M. (1991). Cognitive-behavioral treatment of chronically parasuicidal borderline patients. Archives of General Psychiatry, 48(12), 1060-1064. MacLeod, A.K. (1998). Recovery of positive future thinking within a high-risk parasuicide group: Results from a pilot randomized controlled trial. British Journal of Clinical Psychology., 37(4), 371-379. Marangell LB, Dennehy EB, Wisniewski SR, Bauer MS, Miyahara S, Allen MH, Martinez M, Al Jurdi RK, Thase ME. (2008). Case-control analyses of the impact of pharmacotherapy on prospectively observed suicide attempts and completed suicides in bipolar disorder: findings from STEP-BD. J Clin Psychiatry, 69(6): 916-22. Martinez, C., Rietbrock, S., Wise, L., Ashby, D., Chick, J., Moseley, J., Evans, S., Gunnell, D. (2005). Antidepressant treatment and the risk of fatal and non-fatal self harm in first episode depression: nested case-control study. British Medical Journal, 330(7488), 389. McLeavy, B.C., Daly, R.J., Ludgate, J.W., & Murray, C.M. (1994). Interpersonal problem solving skills training in the treatment of self-poisoning patients, Suicide and Life Threatening Behaviour, 24(4), 382-394. Meltzer, H.Y. (1998). Suicide in schizophrenia: Risk factors and clozapine treatment. Journal of Morgan, O.W., Griffiths, C., & Majeed, A. (2004). Association between mortality from suicide in England and antidepressant prescribing: an ecological study. BMC Public Health, 4(1), 63. Motto, J.A., & Bostrom, A.G. (2001). A randomized controlled trial of postcrisis suicide prevention. Psychiatric Services, 52(6), 828-833. Ohberg, A., Vuori, E., Klaukka, T., & Lonnqvist, J. (1998). Antidepressants and suicide mortality. Journal of Affective Disorders, 50(2-3),225-233. Olfson M, Marcus SC, Druss BG. (2008). Effects of Food and Drug Administration warnings on antidepressant use in a national sample. Arch Gen Psychiatry, 65(1):94-101. Olfson M, Shaffer D, Marcus SC, Greenberg T. (2003). Relationship between antidepressant medication treatment and suicide in adolescents. Arch Gen Psychiatry, 60(10):978-82. Oquendo, M.A., Kamali, M., Ellis, S.P., Grunebaum, M.F., Malone, K.M., Brodsky, B.S., Sackeim, H.A., & Mann, J.J. (2002). Adequacy of antidepressant treatment after discharge and the occurrence of suicidal acts in major depression: A prospective study. American Journal of Psychiatry, 159(10), 1746-1751. Raj, A.J., Kumaraiah, M.V., & Bhide, A.V. (2001). Cognitive-Behavioural Intervention in Deliberate Self-Harm. Acta Psychiatrica Scandinavia, 104(5), 340-345. Rathus, J.H., & Miller, A.L. (2002). Dialectical behavior therapy adapted for suicidal adolescents. Suicide and Life Threatening Behavior, 32(2), 146-157. Reith, D.M., Whyte, I., Carter, G., McPherson, M., & Carter, N. (2004). Risk factors for suicide and other deaths following hospital treated self-poisoning in Australia. Australian & New Zealand Journal of Psychiatry, 38(7), 520-525. Rihmer, Z. (2001). Can better recognition and treatment of depression reduce suicide rates? A brief review. European Psychiatry, 16(7), 406-409. Rotheram-Borus, M.J., Piacentini, J., van Rossem, R., Graae, F., Cantwell, C., Castro-Blanco, D., Miller, S., & Feldman, J. (1996). Enhancing treatment adherence with a specialized emergency room program for adolescent suicide attempters. Journal of American Academy of Child and Adolescent Psychiatry, 35(5), 654-663. Rudd, M.D. (1996). Effectiveness of an outpatient intervention targeting suicidal young adults: Preliminary results. Journal of Consulting and Clinical Psychology, 64(1), 179-190. Salkovskis, P.M., Atha, C., & Storer, D. (1990). Cognitive-behavioural problem solving in the treatment of patients who repeatedly attempt suicide. A controlled trial. British Journal of Psychiatry, 157, 871-6. Segal, Z., Vincent, P., & Levitt, A. (2002). Efficacy of combined, sequential and crossover psychotherapy and pharmacotherapy in improving outcomes in depression. Journal of Psychiatry & Neuroscience, 27(4), 281-290. Shah, R., Uren, Z., Baker, A., & Majeed, A. (2001). Deaths from antidepressants in England and Wales 1993-1997: Analysis of a new national database. Psychological Medicine, 31(7), 1203-1210. Storosum, J.G., van Zwieten, B.J., van den Brink, W., Gersons, B.P.R., & Broekmans, A.W. (2001). Suicide risk in placebo-controlled studies of major depression. American Journal of Psychiatry, 158(8), 1271-1275. Torhorst, A., Moller, H.-J., Burk, F., Kurz, A., Wachtler, C., & Lauter, H. (1987). The psychiatric management of parasuicide patients: A controlled clinical study comparing different strategies of outpatient treatment. Crisis, 8(1), 53-61. van der Sande, R., van Rooijen, L., Buskens, E., Allart, E., Hawton, K., van der Graaf, Y., & van Engeland, H. (1997). Intensive in-patient and community intervention versus routine care after attempted suicide. A randomised controlled intervention study. British Journal of Psychiatry, 171, 35-41. van Heeringen, C., Jannes, S., Buylaert, W., Henderick, H., & De Bacquer, D. (1995). The management of non-compliance with referral to out-patient after-care among attempted suicide patients: a controlled intervention study. Psychological Medicine, 25(5), 963-970. van Praag, H M. (2002). Why has the antidepressant era not shown a significant drop in suicide Vitiello B. Combined Cognitive-Behavioural Therapy and Pharmacotherapy for Adolescent Depression: Does it Improve Outcomes Compared with Monotherapy? CNS Drugs. 2009;23(4):271-80. Welu, T.C. (1977). A follow-up program for suicide attempters: Evaluation of effectiveness. Suicide & Life-Threatening Behavior, 7(1), 17-30 Weisberg HI, Hayden VC, Pontes VP. (2009). Selection criteria and generalizability within the counterfactual framework: explaining the paradox of antidepressant-induced suicidality? Clin Trials, 6(2):109-18. Wheeler BW, Gunnell D, Metcalfe C, Stephens P, Martin RM. (2008). The population impact on incidence of suicide and non-fatal self harm of regulatory action against the use of selective serotonin reuptake inhibitors in under 18s in the United Kingdom: ecological study. BMJ, 336(7643):542-5. Whittington CJ, Kendall T, Fonagy P, Cottrell D, Cotgrove A, Boddington E. (2004). Selective serotonin reuptake inhibitors in childhood depression: systematic review of published versus unpublished data. Lancet, 363(9418):1341-5. Wisniewski SR, Rush AJ, Nierenberg AA, Gaynes BN, Warden D, Luther JF, McGrath PJ, Lavori PW, Thase ME, Fava M, Trivedi MH. (2009). Can phase III trial results of antidepressant medications be generalized to clinical practice? A STAR*D report. Am J Psychiatry, 166(5):599-607. Wood, A., Trainor, G., Rothwell, J., Moore, A., & Harrington, R. (2001). Randomized trial of group therapy for repeated deliberate self-harm in adolescents. Journal of the American Academy of Child and Adolescent Psychiatry, 40(11), 1246-1253. Zonda, T. (2003). Suicide rates in Hungary do not correlate negatively with reported rates of depression and with the number of general practitioners. Archives of Suicide Research, 7(1), 61-67.


All newly approved drugs will default to non-preferred status until a full clinical review by the national pharmacy and therap

CIGNA Drug List Changes – Second Quarter 2009 CIGNA periodically reviews its drug list to promote continued effectiveness. Based on that review, the following changes have been made to the CIGNA drug list from April 1, 2009 to June 30, 2009. Drugs marked with an (*), (^), or (~) indicate that prior authorization, quantity limit, or step therapy is required, respectively. Note: This list

Question Paper Preview  Question Paper Name: Assistant Prof. General Surgery - 2012  Creation Date: 2012-06-28 12:19:42.0  Cut Off: 0  Duration: 120  Status: Sealed Section 1 Question id : 147163 (Correct + 1.0 , Wrong - 0.33) Which one of the following is the ideal treatment of Alkaline Reflux Gastritis after Billroth II gastrectomy 1. Conversion of Billroth II to B

Copyright © 2010-2014 Health Drug Pdf